{"id":58983,"date":"2024-03-05T01:02:22","date_gmt":"2024-03-05T00:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/"},"modified":"2024-03-05T01:02:22","modified_gmt":"2024-03-05T00:02:22","slug":"ahf-urges-who-save-critical-hiv-tech","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/","title":{"rendered":"AHF Urges WHO: Save Critical HIV Tech"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–#AIDS<\/a>—AIDS Healthcare Foundation<\/a> (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing equipment and any necessary commodities that ensure proper functioning.<\/p>\n

\n\u201cWorking in 46 countries, AHF country teams are seeing the consequences of Abbott\u2019s and BD\u2019s decisions firsthand, particularly in Africa and Asia. POC CD4 machines are scarce, if countries have them at all, along with the needed reagent cartridges that allow for 20-minute results. The companies have also stopped making service calls on existing equipment, abandoning patients and leaving healthcare workers empty-handed,\u201d said AHF Senior Global Medical Director Dr. Adele Schwartz Benzaken. \u201cWe urge the WHO to speak up and call on makers of CD4 testing equipment to begin producing the machines and reagents immediately, along with providing support to existing equipment in the field, as many are failing globally.\u201d<\/p>\n

\nA previous, yet now reversed, shift in preference by WHO from CD4 to viral load testing to assess the health of HIV-positive patients caused manufacturers of CD4 machines to announce a dangerous wind down in production, of which AHF warned about<\/a>.<\/p>\n

\nCD4 testing shows how HIV damages our immune system since the virus targets and destroys CD4 cells. While CD4 count is not vital for HIV diagnosis, it\u2019s extremely important upon diagnosis, as the patient\u2019s condition may have already progressed to AIDS\u2014thus essential to the HIV continuum of care.<\/p>\n

\nAbout AIDS Healthcare Foundation (AHF)<\/b><\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea, <\/b>Senior Director, Communications, AHF
\n
+1 323 308 1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a><\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy & Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@aidshealth.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–#AIDS—AIDS Healthcare Foundation (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing equipment and any necessary commodities that ensure proper functioning. \u201cWorking in 46 countries, AHF country teams are seeing the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58983","6":"format-standard","7":"category-industry"},"yoast_head":"\nAHF Urges WHO: Save Critical HIV Tech - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AHF Urges WHO: Save Critical HIV Tech - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–#AIDS—AIDS Healthcare Foundation (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing equipment and any necessary commodities that ensure proper functioning. \u201cWorking in 46 countries, AHF country teams are seeing the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-05T00:02:22+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AHF Urges WHO: Save Critical HIV Tech\",\"datePublished\":\"2024-03-05T00:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/\"},\"wordCount\":369,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/\",\"name\":\"AHF Urges WHO: Save Critical HIV Tech - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2024-03-05T00:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-urges-who-save-critical-hiv-tech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AHF Urges WHO: Save Critical HIV Tech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AHF Urges WHO: Save Critical HIV Tech - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/","og_locale":"en_US","og_type":"article","og_title":"AHF Urges WHO: Save Critical HIV Tech - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–#AIDS—AIDS Healthcare Foundation (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing equipment and any necessary commodities that ensure proper functioning. \u201cWorking in 46 countries, AHF country teams are seeing the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/","og_site_name":"Pharma Trend","article_published_time":"2024-03-05T00:02:22+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AHF Urges WHO: Save Critical HIV Tech","datePublished":"2024-03-05T00:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/"},"wordCount":369,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/","url":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/","name":"AHF Urges WHO: Save Critical HIV Tech - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2024-03-05T00:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ahf-urges-who-save-critical-hiv-tech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AHF Urges WHO: Save Critical HIV Tech"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58983"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58983\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}